1. Home
  2. Labeler Index
  3. Acella Pharmaceuticals, Llc
  4. 42192-329
  5. FDA Recall: Np Thyroid 30

FDA Recall Np Thyroid 30

View Recall Number, Date, Reasons, Quantity

FDA Recall Enforcement Reports

The last Recall Enforcement Report for Np Thyroid 30 with NDC 42192-329 was initiated on 04-29-2021 as a Class I recall due to subpotent drug The latest recall number for this product is D-0396-2021 and the recall is currently terminated as of 03-13-2024 .

Recall Number Initiation Date Report Date Recall Classification Product Quantity Product Description Status
D-0396-202104-29-202106-02-2021Class Ia) 113,019 bottles; b) 44,900 bottlesNP Thyroid 30 Thyroid Tablets, USP 1/2 grain (30 mg), packaged in a) 100-count bottles (NDC 42192-329-01) and b) 7-count bottles (NDC 42192-329-07), Rx Only, Manufactured For: Acella Pharmaceuticals, LLC Alpharetta, GA 30005Terminated
D-1298-202005-22-202006-10-2020Class I112,140 bottlesNP Thyroid 30, Thyroid Tablets, USP, 1/2 grain (30 mg), 100-count bottles, Rx Only, Manufactured For: Acella Pharmaceuticals, LLC, Alpharetta, GA 30005, NDC 42192-329-01.Terminated

What is the Enforcement Report?

All drug recalls are monitored by the Food and Drug Administration (FDA) and are included in the Enforcement Report once they are properly classified. The FDA will determine if a firm's removal or correction actions of a marked product meet the requirements to be considered a "recall". The FDA will also determine the public hazard assessment and a recall classification will be published in the Enforcement Report.